See how top analysts and institutions rate CX — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Scotiabank | Downgrade | Sector Outperform → Sector Perform | $11.10 | 2025-10-21 |
| BofA Securities | Upgrade | Neutral → Buy | 2025-10-15 | |
| Citigroup | Downgrade | Buy → Neutral | $10 | 2025-10-13 |
| JP Morgan | Upgrade | Neutral → Overweight | $10.50 | 2025-08-26 |
| Itau BBA | Downgrade | Outperform → Market Perform | 2025-06-03 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 4 | 4 | 6 | 0 | 1 |
| October 2025 | 5 | 4 | 4 | 0 | 1 |
| September 2025 | 5 | 4 | 4 | 0 | 1 |
| July 2025 | 4 | 4 | 5 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for CX, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
